formerly SaleMove

This brings Glia’s total fundraising to $29 million as Insight Venture Partners joins current investors Tola Capital, Wildcat Capital Management, and …

NEW YORK and TARTU, Estonia and TALLINN, Estonia, March 13, 2019 /PRNewswire/ — Glia (formerly SaleMove), a leading digital customer service platform for financial services companies, today announced that it has raised $20 million in additional funding led by Insight Venture Partners, and joined by existing investors. This brings Glia’s total fundraising to $29 million as Insight Venture Partners joins current investors Tola Capital, Wildcat Capital Management, and Grassy Creek, and Entrepreneurs Roundtable Accelerator. As part of the investment, Lonne Jaffe, Managing Director at Insight Venture Partners, will join Glia’s board of directors.

“We are proud to partner with Glia to transform how businesses connect with customers,” said Lonne Jaffe, Managing Director at Insight Venture Partners. “Glia’s innovative technology includes an elegant blend of CoBrowsing, video chat, voice communications, and a machine learning-powered chatbot chassis that works across Amazon Lex, Google Dialogflow, IBM Watson and more. Glia is one of the shining stars of the New York City technology ecosystem, and we’re excited to get the chance to provide the fantastic team at Glia with the capital and scaling support needed to continue their rapid growth in 2019 and beyond.”

Glia plans to expand its product development, sales, solutions, and marketing organizations, growing the employee headcount and infrastructure to further accelerate Glia’s mission to transform how financial institutions connect with their customers using Messaging, Video, Voice, CoBrowsing, and Artificial Intelligence.

“Insight has a long history and excellent track record of working with best-in-class SaaS companies,” said Dan Michaeli, Co-Founder and CEO at Glia. “By adding an investor as strong and experienced as Insight, we are poised to rapidly expand Glia’s market reach. Almost every interaction between businesses and customers today involves a screen, yet the main method of getting in touch is still an old-school phone call. Over the next 3-5 years, the move from phone-first to digital-first communication will define the businesses that win customer experience in their category. Insight’s successes in the enterprise technology space gives us great confidence in their deep understanding of these trends and we are energized to partner with them.”

This round of funding builds on a 2018 in which Glia had substantial success and growth across the entire enterprise as well as recognition by industry leaders.

  • >100% ARR growth year over year. For the third straight year, Glia saw a more than doubling in annual recurring revenue across its customer base. Supported by both additions of new logos in the Americas, EMEA, and APAC.
  • Product. Glia launched many product features and enhancements to increase functionality and performance in 2018, with two major product additions:
    • Glia’s Voice Platform embraces a future where customers will connect with businesses using digital voice rather than legacy phone numbers. The platform seamlessly integrates with Glia’s Video, CoBrowsing, Messaging and AI solution to create a holistic System of Engagement.
    • With companies struggling to provide cohesion for the large number of chatbot deployments across multiple use cases, Glia created the first ever AI Management Platform that enables companies to integrate and manage chatbots from multiple partners (Amazon Lex, Google Dialogflow, IBM Watson, etc.). This management layer allows businesses to treat chatbots like human agents by easily evaluating performance with standard metrics/data and creating chatbot teams.
  • Industry Recognition. Glia was highlighted by Forrester in Kate Leggett’s recent report, How To Build A Modern Agent Desktop And Transform Customer Service Experiences.
  • Hiring. Glia saw 50% employee growth globally across the United States and Estonia, and expanded the executive team with key hires including industry veteran John Fernandez who joins the company as Senior Vice President of Marketing.
  • Awards. Glia continued its track record of winning key industry awards and recognition at events in the Americas and EMEA, including several best in show awards:
    • Best In Show, Orion Ascent/FUSE Conference (Miami Beach, September 2018)
    • Best in Show, Dig-In Insure Analytics and AI (New York, November 2018)
    • Best in Show, Finovate Europe (London, February 2019), marking the 5th time Glia has won Best in Show at a Finovate event
    • Best in Show, Credit Union National Association Governmental Affairs Conference (Washington D.C., March 2019)
  • Re-Brand. Formerly known as SaleMove, the company re-branded as Glia in February. From the ancient Greek for “glue”, Glia are the most numerous cells in the brain that provide physical and nutritional support for neurons. In short, your glia are the infrastructure which allows for all of the communication to take place in the nervous system. Just like the glia in the brain, Glia the company provides the infrastructure for companies to connect with their customers using Messaging, Video, CoBrowsing and AI.

Speaking about the re-brand, Glia Co-Founder and Chief Executive Officer Dan Michaeli stated “When we first started the company, we believed that we could build a platform in order to facilitate more sales, hence SaleMove. As we’ve built on this initial vision, our customers have found many ingenious uses for our functionality that we didn’t imagine at the time. We realize now that the platform does so much more than move sales, so we’ve made the decision to build a brand which supports that wider vision of the value our customers are achieving.”

About Glia

Glia creates digital-first moments that simplify and transform communications between financial institutions and their customers using Messaging, Video, Voice, CoBrowsing, and Artificial Intelligence. Fortune 500 companies that have high-consideration sales and support experiences need to deliver choice, continuity, and speed to their customers. Glia transcends the channel discussion to focus on what matters – customers. Glia is backed by leading venture capital investors including Insight Venture Partners, Tola Capital, Wildcat Capital Management, and Grassy Creek, and Entrepreneurs Roundtable Accelerator. Glia is headquartered in New York City and has additional offices in Tartu and Tallinn, Estonia. For more information, visit www.glia.com.

About Insight Venture Partners

Insight Venture Partners is a leading global venture capital and private equity firm investing in high- growth technology and software companies that are driving transformative change in their industries. Founded in 1995, Insight currently has over $20 billion of assets under management and has cumulatively invested in more than 300 companies worldwide. Our mission is to find, fund, and work successfully with visionary executives, providing them with practical, hands-on growth expertise to foster long-term success. Across our people and our portfolio, we encourage a culture around a core belief: growth equals opportunity. For more information on Insight and all its investments, visit www.insightpartners.com or follow us on Twitter @insightpartners.

Related Posts:

  • No Related Posts

Which stock will you choose? Marathon Patent Group, Inc. (NASDAQ:MARA), BlackRock, Inc …

BlackRock, Inc. (NYSE:BLK), closed the last trading session at $427.84 with decrease of $-0.260000000000048 or -0.06 percent against the opening …

Marathon Patent Group, Inc. (NASDAQ:MARA)

Marathon Patent Group, Inc. (NASDAQ:MARA), ended its previous trading session at $0.62 showing a gain of 0 or 0.39 percent with respect to the price of $0.62 when stock market opened. The company traded 285670 shares over the course of the trading day. Giving the average volume of 630.88 Million over the course of 3 consecutive months. Which signifies a pretty good change over the time with its shares outstanding of 25.91 Million.

Marathon Patent Group, Inc. (NASDAQ:MARA) is currently trading lower than its price target which is set to $4 by the analyst. The stock is -75.69% Below its 1-Year High which is $2.55. MARA has a difference of 88.34% from its 1 year low which stands at $0.33. The company is currently rated by analyst who are keeping a close eye on the stock as 0. Where 1 means Buy, 2.5 meaning Hold and 5 as Sell.

Marathon Patent Group, Inc. (NASDAQ:MARA) Performance Snapshot

The stock performed exceptionally bad in the previous week which depicts an decrease of -4.63 percent in the shares price. The company added about 20.37% in its share price over 1-Month. While taking about the performance of the stock over 1-year interval is -59.52 Percent. MARA currently shows 71.15% as its year to date performance.

Marathon Patent Group, Inc. (NASDAQ:MARA) Price Insight

The stock needs to grow about $3.38 to reach its price target. In order to seek the stock’s directional movements, 20-Days, 50 Days and 200-Days moving averages are -0.83%, 27.88% and -18.83 percent respectively. The stock trades about 7.69 percent of its Float giving its total shares Outstanding are 25.91 Million. MARA lost about -29.76 percent in 6 months showing its Average True Range of 0.07. The company currently has a RSI and Beta of 54.47 and 2.28.

While talking about Marathon Patent Group, Inc. (NASDAQ:MARA) valuation ratios, the stock trades with a P/S and P/B of 13.38 and 2.38 which is significantly better and attractive as compared to its peers.

BlackRock, Inc. (NYSE:BLK)

BlackRock, Inc. (NYSE:BLK), closed the last trading session at $427.84 with decrease of $-0.260000000000048 or -0.06 percent against the opening price of $428.1. The trading day volume of the company stands at 504679 shares while the average trading volume of BlackRock, Inc. (NYSE:BLK) is 688.93 Million over the course of 3 consecutive months. Which signifies a pretty good change over the time with its shares outstanding of 158.74 Million.

The price target of BlackRock, Inc. (NYSE:BLK) is currently set at 473.33 by the analysts. The stock is $-26.08 Below its 1-Year High which is $578.80. BLK hit its 1-Year low price of $360.79. The company is currently rated by analyst who are keeping a close eye on the stock as 1.9. Where 1 means Buy, 2.5 meaning Hold and 5 as Sell.

Performance Indicators of BlackRock, Inc. (NYSE:BLK)

The value of the stock decreased by -1.08% during the previous week performance. Looking at the 1 month performance of BlackRock, Inc. (NYSE:BLK), the stock jumped 3.91%. While the 1 year performance shows a negative percentage of -25.87 and year to date performance stands at 8.92%.

BlackRock, Inc. (NYSE:BLK) Analytical Review

The stock needs to grow about $45.49 to reach its price target. In order to seek the stock’s directional movements, 20-Days, 50 Days and 200-Days moving averages are -0.98%, 2.99% and -5.29 percent respectively. The stock trades about 0.73 percent of its Float giving its total shares Outstanding are 158.74 Million. BLK gained about -9.25 percent in 6 months showing its Average True Range of 7.36. The company currently has a RSI and Beta of 51.6 and 1.44.

While talking about BlackRock, Inc. (NYSE:BLK) valuation ratios, the stock trades with a P/S and P/B of 4.78 and 2.1 which is significantly better and attractive as compared to its peers.

Related Posts:

  • No Related Posts

Glia raises $20 million to unify voice, video, and chatbots

Today the company announced that it has raised $20 million in series B funding led by Insight Venture Partners, with participation from current …

Multimodality is fast becoming the norm in the $350 billion customer service industry. According to research published last year by Vonage company NewVoiceMedia, three-quarters of customers prefer to have their queries handled by a live agent, while the remaining 25 percent favor chatbots and other self-service alternatives. A separate survey by Econsultancy found that 51 percent prefer live chat for the freedom it affords. And, according to Zendesk, over 80 percent report that they’ve had questions satisfactorily answered via voice, email, and text messaging.

Glia (formerly SaleMove), a New York startup cofounded by Justin DiPietro, Carlos Paniagua, and now-CEO Dan Michaeli in 2012, aims to capitalize on the trend with an omnichannel customer service platform that supports text, phone calls, video chat, and more. Today the company announced that it has raised $20 million in series B funding led by Insight Venture Partners, with participation from current investors Tola Capital, Wildcat Capital Management, Grassy Creek, and Entrepreneurs Roundtable Accelerator, bringing its total raised to $29 million.

It’s been an eventful year for Glia, according to Michaeli. In 2018, the company saw annual recurring revenue grow 100 percent year-over-year across its customer base of financial services companies, and its workforce doubled globally. The funding, he says, will be used to expand Glia’s geographic footprint, particularly in product development, sales, marketing, and infrastructure.

“Almost every interaction between businesses and customers today involves a screen, yet the main method of getting in touch is still an old-school phone call,” he added. “Over the next three to five years, the move from ‘phone-first’ to ‘digital-first’ communication will define the businesses that win customer experience in their category.”

Glia

Glia matches customers with support staff by marrying video with messaging and voice. Michaeli claims its chatbot framework — AI Mangement Platform — is a key differentiator; it integrates and tracks bots powered by IBM’s Watson, Amazon’s Lex, Google’s Dialogflow, and other natural dialogue backends, which managers can divvy up into teams.

Customers who opt for human help can participate via Glia in live video sessions in which reps provide guided product tours and answer questions verbally or via text. Niftily, folks who dial in are assigned a unique ID that Glia uses to intelligently route them to the person they last spoke with.

No matter which medium customers choose in Glia, its CoBrowsing tool enables agents to walk people through apps and websites with a virtual mouse cursor. Michaeli claims that this option (in tandem with the rest of Glia’s suite) has delivered some of its clients 20 percent faster issue reduction, a 4 times increase in application throughput, and an 18 percent reduction in average handle time.

“We are proud to partner with Glia to transform how businesses connect with customers,” said Insight Venture Partners’ Lonne Jaffe, who plans to join Glia’s board of directors. “Glia’s innovative technology includes an elegant blend of … video chat and voice communications and a machine learning-powered chatbot chassis that works across [platforms]. Glia is one of the shining stars of the New York City technology ecosystem, and we’re excited to get the chance to provide the team with the capital and scaling support needed to continue their rapid growth in 2019 and beyond.”

Sign up for Funding Daily: Get the latest news in your inbox every weekday.

Related Posts:

  • No Related Posts

Fagan Associates Position in Citigroup (C) Has Cut by $313716; As Conmed (CNMD) Market …

N : CITIGROUP RAISES TARGET PRICE TO $19 FROM $18; 04/04/2018 – Brian Friedman, President of Leucadia National Corporation, and Bonnie …

CONMED Corporation (NASDAQ:CNMD) Logo

Granahan Investment Management Inc decreased its stake in Conmed Corp (CNMD) by 19.48% based on its latest 2018Q4 regulatory filing with the SEC. Granahan Investment Management Inc sold 54,699 shares as the company’s stock rose 12.52% with the market. The hedge fund held 226,042 shares of the electromedical & electrotherapeutic apparatus company at the end of 2018Q4, valued at $14.51M, down from 280,741 at the end of the previous reported quarter. Granahan Investment Management Inc who had been investing in Conmed Corp for a number of months, seems to be less bullish one the $2.21B market cap company. The stock increased 0.81% or $0.63 during the last trading session, reaching $78.57. About 151,550 shares traded. CONMED Corporation (NASDAQ:CNMD) has risen 29.09% since March 12, 2018 and is uptrending. It has outperformed by 24.72% the S&P500. Some Historical CNMD News: 25/04/2018 – CONMED 1Q EPS 37c; 25/04/2018 – CONMED SEES FY ADJ EPS $2.15 TO $2.20, EST. $2.14; 24/03/2018 – FDA: ConMed Corporation- MINI INFANT

Fagan Associates Inc decreased its stake in Citigroup Inc (C) by 12.9% based on its latest 2018Q4 regulatory filing with the SEC. Fagan Associates Inc sold 6,033 shares as the company’s stock declined 2.79% while stock markets rallied. The institutional investor held 40,728 shares of the major banks company at the end of 2018Q4, valued at $2.12M, down from 46,761 at the end of the previous reported quarter. Fagan Associates Inc who had been investing in Citigroup Inc for a number of months, seems to be less bullish one the $147.01 billion market cap company. The stock increased 0.80% or $0.5 during the last trading session, reaching $62.81. About 14.77 million shares traded. Citigroup Inc. (NYSE:C) has declined 13.45% since March 12, 2018 and is downtrending. It has underperformed by 17.82% the S&P500. Some Historical C News: 22/03/2018 – Citigroup to restrict commercial borrowers that sell firearms; 30/05/2018 – CITIGROUP CEO MIKE CORBAT COMMENTS AT INVESTOR CONFERENCE; 06/03/2018 – RPT-CITIGROUP CFO SAYS ADDING DIGITAL SERVICES LAYS GROUNDWORK FOR NATIONAL CONSUMER BANKING; 03/05/2018 – Bulgaria’s BEH picks Citi as global coordinator for bond issue; 17/05/2018 – EGYPT’S BANQUE MISR HIRES CITIGROUP FOR $500 MLN LOAN; 08/05/2018 – KEANE GROUP INC FRAC.N : CITIGROUP RAISES TARGET PRICE TO $19 FROM $18; 04/04/2018 – Brian Friedman, President of Leucadia National Corporation, and Bonnie Howard, Former Chief Auditor of Citigroup, appointed to; 30/05/2018 – CITIGROUP CEO MIKE CORBAT ENDS COMMENTS AT INVESTOR CONFERENCE; 10/04/2018 – CITI, GIB CAPITAL, GOLDMAN SACHS, HSBC, MORGAN STANLEY HIRED AS COORDINATORS FOR SAUDI DOLLAR BOND -LEAD BANK; 08/05/2018 – SoFi Is Said to Plan Credit Card With Help From Former Citi Exec

Analysts await CONMED Corporation (NASDAQ:CNMD) to report earnings on April, 24. They expect $0.54 earnings per share, up 1.89% or $0.01 from last year’s $0.53 per share. CNMD’s profit will be $15.20M for 36.38 P/E if the $0.54 EPS becomes a reality. After $0.73 actual earnings per share reported by CONMED Corporation for the previous quarter, Wall Street now forecasts -26.03% negative EPS growth.

Investors sentiment decreased to 1.51 in 2018 Q4. Its down 0.17, from 1.68 in 2018Q3. It turned negative, as 23 investors sold CNMD shares while 45 reduced holdings. 37 funds opened positions while 66 raised stakes. 26.54 million shares or 1.88% more from 26.05 million shares in 2018Q3 were reported. Hillsdale Mgmt Inc stated it has 27,400 shares or 0.21% of all its holdings. Mackay Shields Lc owns 22,561 shares. Tower Cap Ltd Liability Corporation (Trc) stated it has 180 shares. Zurcher Kantonalbank (Zurich Cantonalbank) holds 1,864 shares or 0% of its portfolio. Nebraska-based Cwm Ltd Liability Corp has invested 0% in CONMED Corporation (NASDAQ:CNMD). Cna Finance Corporation holds 0.08% in CONMED Corporation (NASDAQ:CNMD) or 5,503 shares. Bessemer Grp has invested 0.01% in CONMED Corporation (NASDAQ:CNMD). Huber Ltd Liability invested 0.64% of its portfolio in CONMED Corporation (NASDAQ:CNMD). Fruth Inv Mgmt stated it has 3,000 shares. Mason Street Advsrs Limited Liability has 8,037 shares. Sun Life Financial Incorporated stated it has 0.06% in CONMED Corporation (NASDAQ:CNMD). Tci Wealth Advsrs reported 6 shares. First Mercantile Comm holds 0.03% in CONMED Corporation (NASDAQ:CNMD) or 1,745 shares. Greenwood Cap Assoc Ltd Liability Corporation has invested 0.07% in CONMED Corporation (NASDAQ:CNMD). D E Shaw & Inc has invested 0% of its portfolio in CONMED Corporation (NASDAQ:CNMD).

More notable recent CONMED Corporation (NASDAQ:CNMD) news were published by: Nasdaq.com which released: “Genomic Health (GHDX) Q4 Earnings Beat Estimates, Margins Up – Nasdaq” on February 21, 2019, also Nasdaq.com with their article: “Cryolife (CRY) Earnings Miss, Revenues Top Estimates in Q4 – Nasdaq” published on February 18, 2019, Nasdaq.com published: “Avanos (AVNS) Q4 Earnings Beat, Revenues Miss, Shares Down – Nasdaq” on March 12, 2019. More interesting news about CONMED Corporation (NASDAQ:CNMD) were released by: Nasdaq.com and their article: “HMS Holdings’ (HMSY) Q4 Earnings Beat, Revenues Rise Y/Y – Nasdaq” published on March 05, 2019 as well as Nasdaq.com‘s news article titled: “Daily Dividend Report: HD, LIN, BMO, UBSI, CNMD – Nasdaq” with publication date: February 26, 2019.

Granahan Investment Management Inc, which manages about $3.81B and $1.41 billion US Long portfolio, upped its stake in Chegg Inc (NYSE:CHGG) by 130,956 shares to 510,900 shares, valued at $14.52 million in 2018Q4, according to the filing. It also increased its holding in Weight Watchers (NYSE:WTW) by 203,154 shares in the quarter, for a total of 602,508 shares, and has risen its stake in Carbonite Inc (NASDAQ:CARB).

Since September 14, 2018, it had 1 buy, and 2 selling transactions for $336,069 activity. Shares for $120,651 were sold by Peters Stanley W III on Friday, September 14. Cohen Heather L bought $61,742 worth of stock or 900 shares.

Analysts await Citigroup Inc. (NYSE:C) to report earnings on April, 12. They expect $1.83 EPS, up 8.93% or $0.15 from last year’s $1.68 per share. C’s profit will be $4.28 billion for 8.58 P/E if the $1.83 EPS becomes a reality. After $1.61 actual EPS reported by Citigroup Inc. for the previous quarter, Wall Street now forecasts 13.66% EPS growth.

Investors sentiment decreased to 0.66 in Q4 2018. Its down 0.36, from 1.02 in 2018Q3. It is negative, as 130 investors sold C shares while 533 reduced holdings. 112 funds opened positions while 325 raised stakes. 1.78 billion shares or 0.99% less from 1.80 billion shares in 2018Q3 were reported. Steinberg Glob Asset holds 0.15% or 16,439 shares. 109,857 were reported by Cubist Systematic Strategies Lc. Moreover, Supplemental Annuity Collective Tru Of Nj has 1.07% invested in Citigroup Inc. (NYSE:C). Conning Incorporated holds 0.09% of its portfolio in Citigroup Inc. (NYSE:C) for 51,800 shares. B Riley Wealth Inc holds 0.13% or 11,670 shares. Welch Ltd Liability Corporation New York reported 4.34% stake. Skba Capital Mgmt Limited Liability Company accumulated 192,100 shares. Personal Capital Advisors stated it has 0% of its portfolio in Citigroup Inc. (NYSE:C). Northpointe Cap Limited Co accumulated 0.73% or 61,863 shares. Eulav Asset Mngmt holds 0.22% or 85,000 shares in its portfolio. Johnson Invest Counsel invested 0.02% in Citigroup Inc. (NYSE:C). Dimensional Fund LP holds 17.39M shares or 0.41% of its portfolio. Glacier Peak Cap Limited Co reported 27,000 shares. 20,484 were accumulated by Pinnacle Ltd Limited Liability Company. Qci Asset Mngmt Ny invested in 0.03% or 5,606 shares.

Since February 13, 2019, it had 0 buys, and 2 insider sales for $791,051 activity. 5,420 shares were sold by Hu W. Bradford, worth $348,343.

More notable recent Citigroup Inc. (NYSE:C) news were published by: Investorplace.com which released: “The 10 Best Cheap Stocks to Buy Right Now – Investorplace.com” on February 19, 2019, also Seekingalpha.com with their article: “Antero Resources – Corporate Catalysts On The Horizon – Antero Resources Corporation (NYSE:AR) – Seeking Alpha” published on March 12, 2019, Thestreet.com published: “Citigroup Shares Get Bump From Jefferies Upgrade – TheStreet.com” on February 22, 2019. More interesting news about Citigroup Inc. (NYSE:C) were released by: Benzinga.com and their article: “Jefferies Upgrades Citi (NYSE:C) To Buy, Sounds Optimistic Note On Latin American Business – Benzinga” published on February 22, 2019 as well as Globenewswire.com‘s news article titled: “Apollo Commercial Real Estate Finance, Inc. Announces Preferred Dividends – GlobeNewswire” with publication date: March 12, 2019.

CONMED Corporation (NASDAQ:CNMD) Institutional Positions Chart

Related Posts:

  • No Related Posts

As Enstar Group Limited (ESGR) Stock Value Declined, Holder Akre Capital Management Lowered …

CHARLES RIVER VENTURES; 10/05/2018 – Charles River Labs Sees FY Adj EPS $5.77-Adj EPS $5.92; 15/05/2018 – Charles River Presenting at …

Charles River Laboratories International, Inc. (NYSE:CRL) Logo

Akre Capital Management Llc decreased its stake in Enstar Group Limited (ESGR) by 23.55% based on its latest 2018Q4 regulatory filing with the SEC. Akre Capital Management Llc sold 275,498 shares as the company’s stock declined 5.97% while stock markets rallied. The hedge fund held 894,216 shares of the property-casualty insurers company at the end of 2018Q4, valued at $149.84 million, down from 1.17M at the end of the previous reported quarter. Akre Capital Management Llc who had been investing in Enstar Group Limited for a number of months, seems to be less bullish one the $3.66B market cap company. The stock increased 2.03% or $3.38 during the last trading session, reaching $170.26. About 87,921 shares traded or 105.10% up from the average. Enstar Group Limited (NASDAQ:ESGR) has declined 17.33% since March 12, 2018 and is downtrending. It has underperformed by 21.70% the S&P500. Some Historical ESGR News: 24/05/2018 – Hillhouse Capital Management, Ltd. Reports 9.75% Stake In Enstar Group; 24/05/2018 – HILLHOUSE CAPITAL MANAGEMENT LTD REPORTS 9.75 PCT STAKE IN ENSTAR GROUP LTD AS OF MAY 14 – SEC FILING; 22/05/2018 – Enstar Group Closes Below 200-Day Moving Average: Technicals; 08/05/2018 – ENSTAR GROUP LTD – QTRLY RESULTS HAD NET UNREALIZED LOSSES OF $100.3 MLN ON FIXED MATURITIES INVESTMENTS; 08/05/2018 – Enstar Group 1Q Loss $41.2M; 08/05/2018 ENSTAR GROUP 1Q LOSS/SHR $2.12

New England Research & Management Inc decreased its stake in Charles River Laboratories (CRL) by 69.44% based on its latest 2018Q4 regulatory filing with the SEC. New England Research & Management Inc sold 7,500 shares as the company’s stock rose 4.92% with the market. The institutional investor held 3,300 shares of the health care company at the end of 2018Q4, valued at $373,000, down from 10,800 at the end of the previous reported quarter. New England Research & Management Inc who had been investing in Charles River Laboratories for a number of months, seems to be less bullish one the $6.76 billion market cap company. The stock decreased 0.14% or $0.2 during the last trading session, reaching $140.15. About 154,852 shares traded. Charles River Laboratories International, Inc. (NYSE:CRL) has risen 34.55% since March 12, 2018 and is uptrending. It has outperformed by 30.18% the S&P500. Some Historical CRL News: 09/04/2018 – CHARLES RIVER LABS, PATHOQUEST EXPAND STRATEGIC BIOLOGICS; 26/03/2018 – APRICUS BIOSCIENCES INC – INTEND TO FURTHER CLARIFY DEFICIENCIES RAISED IN CRL AND INFORMATION THAT MAY BE NEEDED TO RESOLVE SUCH DEFICIENCIE; 22/05/2018 – SIGNALFX SAYS $45 MLN IN SERIES D FUNDING LED BY GENERAL CATALYST WITH PARTICIPATION FROM ANDREESSEN HOROWITZ, CHARLES RIVER VENTURES; 10/05/2018 – Charles River Labs Sees FY Adj EPS $5.77-Adj EPS $5.92; 15/05/2018 – Charles River Presenting at Bank of America Conference Tomorrow; 18/05/2018 – AGILE SAYS FDA COULD NOT APPROVE TWIRLA IN CRL; 24/05/2018 – Recro Pharma Will Request a Meeting With FDA to Discuss CRL’s Points; 18/05/2018 – AGILE THERAPEUTICS INC – IN CRL, FDA INFORMED COMPANY THAT TWIRLA NDA COULD NOT BE APPROVED; 09/05/2018 – Lipocine: CRL Also Identified Additional Comments That Are Not Considered Approvability Issues; 10/04/2018 – Charles River Laboratories Focuses on the Future of Oncology at AACR Annual Meeting 2018

Investors sentiment increased to 1.41 in Q4 2018. Its up 0.50, from 0.91 in 2018Q3. It increased, as 10 investors sold ESGR shares while 36 reduced holdings. 19 funds opened positions while 46 raised stakes. 13.26 million shares or 0.36% more from 13.21 million shares in 2018Q3 were reported. Bessemer Gru Incorporated holds 0.01% or 11,124 shares. Invsts holds 0.01% of its portfolio in Enstar Group Limited (NASDAQ:ESGR) for 265,000 shares. Whittier Of Nevada Incorporated reported 0% stake. Moreover, Canada Pension Plan Invest Board has 0.56% invested in Enstar Group Limited (NASDAQ:ESGR). Comerica State Bank holds 48,917 shares. Westpac Bk Corp holds 34,118 shares or 0% of its portfolio. Thompson Siegel Walmsley Ltd Liability Corporation holds 0.01% of its portfolio in Enstar Group Limited (NASDAQ:ESGR) for 3,200 shares. Tiaa Cref Limited Liability Corp reported 23,342 shares or 0% of all its holdings. Sei Investments reported 0% in Enstar Group Limited (NASDAQ:ESGR). Punch Assocs Mgmt owns 36,526 shares. 2,455 were reported by Citadel Ltd. Gsa Prtn Limited Liability Partnership, United Kingdom-based fund reported 1,232 shares. Moreover, National Bank & Trust Of Montreal Can has 0% invested in Enstar Group Limited (NASDAQ:ESGR). Zurcher Kantonalbank (Zurich Cantonalbank), a Switzerland-based fund reported 293 shares. Brown Advisory owns 8,390 shares.

More notable recent Enstar Group Limited (NASDAQ:ESGR) news were published by: Globenewswire.com which released: “Enstar Group Limited Reports Second Quarter Results – GlobeNewswire” on August 02, 2018, also Globenewswire.com with their article: “Enstar Announces Four Reinsurance-To-Close Transactions With AmTrust Syndicates – GlobeNewswire” published on February 15, 2019, Seekingalpha.com published: “Undervalued Preferred Stocks, 9% Return In 4 Months, And Excellent Long-Term Investment By Enstar – Seeking Alpha” on January 24, 2019. More interesting news about Enstar Group Limited (NASDAQ:ESGR) were released by: Seekingalpha.com and their article: “Enstar Group Limited: This 7.00% Preferred Stock Has Begun Trading On The Nasdaq – Seeking Alpha” published on December 05, 2018 as well as Nasdaq.com‘s news article titled: “Enstar and Maiden Agree to New ADC Structure for AmTrust Quota Share Business – Nasdaq” with publication date: March 01, 2019.

New England Research & Management Inc, which manages about $167.47 million and $127.10M US Long portfolio, upped its stake in Carnival Corp. (NYSE:CCL) by 17,878 shares to 34,653 shares, valued at $1.71M in 2018Q4, according to the filing. It also increased its holding in Fedex (NYSE:FDX) by 2,170 shares in the quarter, for a total of 6,445 shares, and has risen its stake in Union Pacific (NYSE:UNP).

Analysts await Charles River Laboratories International, Inc. (NYSE:CRL) to report earnings on May, 9. They expect $1.40 EPS, up 1.45% or $0.02 from last year’s $1.38 per share. CRL’s profit will be $67.52 million for 25.03 P/E if the $1.40 EPS becomes a reality. After $1.49 actual EPS reported by Charles River Laboratories International, Inc. for the previous quarter, Wall Street now forecasts -6.04% negative EPS growth.

Since November 7, 2018, it had 0 buys, and 4 sales for $6.45 million activity. Shares for $148,179 were sold by BERTOLINI ROBERT J on Tuesday, December 4. 23,356 Charles River Laboratories International, Inc. (NYSE:CRL) shares with value of $3.18M were sold by JOHST DAVID P.

Investors sentiment decreased to 1.03 in 2018 Q4. Its down 0.22, from 1.25 in 2018Q3. It worsened, as 18 investors sold CRL shares while 130 reduced holdings. 58 funds opened positions while 94 raised stakes. 46.68 million shares or 3.25% more from 45.21 million shares in 2018Q3 were reported. Jp Marvel Inv Limited Com has 21,560 shares for 0.88% of their portfolio. Tiaa Cref Inv Mngmt Lc has 0.02% invested in Charles River Laboratories International, Inc. (NYSE:CRL). Moreover, Virginia Retirement Et Al has 0.02% invested in Charles River Laboratories International, Inc. (NYSE:CRL). 5,342 are owned by Nuveen Asset Mngmt Limited Liability. Cadence Cap Mgmt Ltd Liability Company invested in 11,604 shares. 4,414 are held by Dupont Capital Management. Wesbanco Natl Bank accumulated 14,284 shares or 0.1% of the stock. Caprock Incorporated invested in 1,819 shares or 0.05% of the stock. Suntrust Banks invested in 8,455 shares or 0.01% of the stock. Moreover, Private Tru Com Na has 0.1% invested in Charles River Laboratories International, Inc. (NYSE:CRL) for 3,911 shares. Creative Planning reported 2,339 shares or 0% of all its holdings. Voya Mngmt Limited Liability Corp holds 0.15% of its portfolio in Charles River Laboratories International, Inc. (NYSE:CRL) for 535,538 shares. Gru One Trading Limited Partnership accumulated 4,062 shares or 0% of the stock. Hsbc Public Lc reported 12,171 shares. United Financial Advisers Limited stated it has 7,905 shares or 0.01% of all its holdings.

Charles River Laboratories International, Inc. (NYSE:CRL) Institutional Positions Chart

Related Posts:

  • No Related Posts